This information was published on 2026-01-21T14:32:25 for IP Right Filed Published.
| Field | Value |
| (210) | 2620439 |
| (220) |
21 Jan 2026
|
| (300) |
US, 17 Nov 2025, 99500515
|
| (511) (510) |
Class 5
Bioavailability enhancing molecular complex as an intermediate product in the manufacture of pharmaceuticals for the treatment of migraines, neurological disorders and central nervous system disorders |
| (540) | MOSEIC |
| (550) | Word |
| (730) |
Axsome Therapeutics, Inc.
|
| (750) |
Griffith Hack
|
Find out more about publications on the About page.